The aim of this observational study is to document the therapeutic use of PASCALLERG ® for hay fever. Based on the survey is a decrease in disease-specific symptoms when taking PASCALLERG ® over a period of 4 weeks will be documented. In addition to the compatibility can be assessed.
There are documented male and female patients over the age of one year who suffer from hay fever. The traetment time is about a period of 4 weeks with PASCALLERG® tablets.
Study Type
OBSERVATIONAL
Enrollment
123
Jennifer Lebert
Giessen, Germany
Efficacy of Pascallerg
Request of Efficacy using a 4-stage scale (very good efficacy, good efficacy, moderate efficacy, no efficacy)
Time frame: appr. 4 weeks after baseline (after appr. 4 weeks of treatment)
Tolerability of Pascallerg
Request of Tolerability using a 2-stage scale (very good tolerability, bad tolerability)
Time frame: app. 4 weeks after baseline (treatment app. for 4 weeks)
Numerical Rating Scale Well Beeing (Pre- Post)
Influence of allergy on the general well-being (scale from 0-no influence to 10 strong influence)
Time frame: Change from Baseline (before treatment; week 0) to last visit (end of observation- approx. 4 weeks after baseline)
Change of Symptom Dry Eyes (Pre- Post)
Request Scale (0=not present, 1=mild, 2=moderate, 3=strong)
Time frame: Change from Baseline (before treatment; week 0) to last visit (end of observation- approx. 4 weeks after baseline)
Change of Symptom Itching Eyes (Pre- Post)
Request Scale (0=not present, 1=mild, 2=moderate, 3=strong)
Time frame: Change from Baseline (before treatment; week 0) to last visit (end of observation- approx. 4 weeks after baseline)
Change of Symptom Burning Eyes (Pre-post)
Request Scale (0=not present, 1=mild, 2=moderate, 3=strong)
Time frame: Change from Baseline (before treatment; week 0) to last visit (end of observation- approx. 4 weeks after baseline)
Change of Symptom Bronchial Complaints (Pre-post)
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Request Scale (0=not present, 1=mild, 2=moderate, 3=strong)
Time frame: Change from Baseline (before treatment; week 0) to last visit (end of observation- approx. 4 weeks after baseline)
Change of Symptom Sneezing (Pre-post)
Request Scale (0=not present, 1=mild, 2=moderate, 3=strong)
Time frame: Change from Baseline (before treatment; week 0) to last visit (end of observation- approx. 4 weeks after baseline)
Change of Symptom Rhinitis (Pre-post)
Request Scale (0=not present, 1=mild, 2=moderate, 3=strong)
Time frame: Change from Baseline (before treatment; week 0) to last visit (end of observation- approx. 4 weeks after baseline)
Change of Symtom Fatigue / Tiredness
Request Scale (0=not present, 1=mild, 2=moderate, 3=strong)
Time frame: Change from Baseline (before treatment; week 0) to last visit (end of observation- approx. 4 weeks after baseline)
Change of Symptom Headache (Pre-post)
Request Scale (0=not present, 1=mild, 2=moderate, 3=strong)
Time frame: Change from Baseline (before treatment; week 0) to last visit (end of observation- approx. 4 weeks after baseline)
Change of Symptom Tearing Eyes (Pre-post)
Request Scale (0=not present, 1=mild, 2=moderate, 3=strong)
Time frame: Change from Baseline (before treatment; week 0) to last visit (end of observation- approx. 4 weeks after baseline)